Close Menu
News Article

Texas Biomed faculty members appointed to national COVID-19 committees

Scientists join collaborators from around the nation to combat COVID-19

San Antonio, Texas (October 15, 2020) – Scientists at Texas Biomedical Research Institute (Texas Biomed) have been selected to serve on seven national scientific committees and working groups related to COVID-19. The national committees connect scientists from around the nation to develop best practices and exchange ideas to combat COVID-19.

“These appointments highlight the expertise and knowledge that Texas Biomed scientists are able to contribute in the many areas of biomedical and scientific research,” said Dr. Joanne Turner, Vice President, Research for Texas Biomed. “We’re performing multiple SARS-CoV-2 research studies with more than 30 completed and active projects, therefore, it’s important for us to be involved in these national discussions.”

Dr. Ricardo Carrion chairs the antibody response subcommittee for Accelerating COVID-19 Therapeutic Interventions & Vaccines Coronavirus Vaccine & Therapy Evaluation Network (ACTIV CoVTen) and co-chairs the National Primate Research Centers (NPRC) coronavirus working group. He along with Dr. Luis Giavedoni meet frequently with collaborators to discuss current and future animal research projects and to identify effective models to study COVID-19.

“As an appointed chair and co-chair, I encourage open discussion and promote collaboration,” Dr. Carrion said. “Scientists are striving toward the same goal, which is to expedite scientific progress and discovery of effective vaccines and treatments for COVID-19. Through these interactions, we share our unique capabilities more broadly and can form new collaborations which generate more synergy and advance discovery.”

Access the list of Texas Biomed’s national committees and subcommittees here, Texas Biomed National Advisory Committees.


Texas Biomed is one of the world’s leading independent biomedical research institutions dedicated to eradicating infection and advancing health worldwide through innovative biomedical research. Texas Biomed partners with researchers and institutions around the world to develop vaccines and therapeutics against viral pathogens causing AIDS, hepatitis, hemorrhagic fever, tuberculosis and parasitic diseases responsible for malaria and schistosomiasis disease. The Institute has programs in host-pathogen interaction, disease intervention and prevention and population health to understand the links between infectious diseases and other diseases such as aging, cardiovascular disease, diabetes and obesity. For more information on Texas Biomed, go to